Crack across Canada: Comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users

Addiction

Volumn 101, Issue 12, 2006, Pages 1760-1770

  Fischer, Benedikt ^a,b   Rehm, Jürgen ^a,b   Patra, Jayadeep ^a,b   Kalousek, Kate ^a,b   Haydon, Emma ^a,c   Tyndall, Mark ^d,e   El Guebaly, Nady ^f  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c YORK UNIVERSITY   (Canada)

^d BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f FOOTHILLS HOSPITAL   (Canada)

Author keywords

Canada; Crack use; Marginalized populations; Prevention; Public health; Social determinants

Indexed keywords

COCAINE; DIAMORPHINE; HEPATITIS C ANTIBODY; HYDROMORPHONE; ILLICIT DRUG; OPIATE; STREET DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANADA; CONTROLLED STUDY; DEPRESSION; DETENTION; DRUG DEPENDENCE; DRUG USE; FEMALE; HEALTH HAZARD; HEALTH STATUS; HEALTH SURVEY; HOMELESSNESS; HUMAN; ILLEGITIMACY; IMMUNOASSAY; INCOME; INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PSYCHIATRIC DIAGNOSIS; QUESTIONNAIRE; RISK ASSESSMENT; SMOKING; SOCIAL ASPECT;

ADULT; CANADA; COCAINE-RELATED DISORDERS; COHORT STUDIES; CRACK COCAINE; CRIME; FEMALE; HEALTH STATUS; HIV ANTIBODIES; HUMANS; MALE; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; STREET DRUGS; URBAN HEALTH;

EID: 33845405571     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2006.01614.x     Document Type: Article

References (89)

1. Federal/Provincial/Territorial Committee on Injection Drug Use. Reducing the Harm Associated with Injecting Drug Use in Canada. Ottawa: Health Canada; 2001.
2. Wall R., Rehm J., Fischer B., Brands B., Gliksman L., Stewart J. et al. The social cost of untreated opiate use. JUrban Health 2001; 77: 688-722.
3. Fischer B., Rehm J., Blitz-Miller T. Injection drug use and preventive measures: a comparison of Canadian and Western European jurisdictions over time. Can Med Assoc J 2000; 162: 1709-13.
4. Cheung Y. W., Erickson P. G., Landau T. Experience of crack use: findings from a community-based sample in Toronto. J Drug Issues 1991; 21: 121-40.
5. Ratner M. S. Sex, drugs and public policy. studying and understanding the sex-for-crack phenomenon. In: Ratner M. S., editor. Crack pipe as pimp: an ethnographic investigation of sex-for-crack exchanges. New York: Lexington Books; 1993, p. 1-35.
6. I-Track. Enhanced Surveillance of Risk Behaviours Among Injecting Drug Users in Canada. Pilot Survey Report. Ottawa: Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Population and Public Health Branch, Health Canada; 2004.
7. Millson P., Myers T., Calzavara L., Rea E., Wallace E., Major C. et al. Prevalence of HIV and Other Bloodborne Viruses and Associated Risk Behaviours in Ontario Injection Drug Users (IDU). Toronto, ON: HIV Social, Behavioural and Epidemiological Studies Unit, Faculty of Medicine, University of Toronto; 1998.
8. Millson P., Myers T., Rankin J., McLaughlin B., Major C., Mindell W. et al. Prevalence of human immunodeficiency virus and associated risk behaviour in injection drug users in Toronto. Can J Public Health 1995; 86: 176-80.
9. Buxton J. Vancouver Drug Use Epidemiology. Vancouver: Canadian Community Epidemiology Network on Drug Use; 2003.
10. Haydon E., Fischer B. Crack use as a public health problem in Canada - call for an evaluation of 'safer crack use kits'. Can J Public Health 2005; 96: 185-8.
11. Wallace J. I., Porter J., Weiner A., Steinberg A. Oral sex, crack smoking, and HIV infection among female sex workers who do not inject drugs. Am J Public Health 1997; 87: 470.
12. Ouellet L., Thorpe L., Huo D., Bailey S., Jimenez A., Johnson W. et al. Prevalence and incidence of HIV among out-of-treatment injecting drug users, Chicago 1994-1996. J Acquir Immune Defic Syndr 2000; 25: 443-50.
13. Faruque S., Edlin B. R., McCoy C. B., Word C. O., Larsen S. A., Schmid D. S. et al. Crack cocaine smoking and oral sores in three inner-city neighborhoods. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 87-92.
14. Thorpe L., Ouellet L., Hershow R., Bailey S., Williams I. I., Monerosso E. The multiperson use of non-syringe injection equipment and risk of hepatitis C infection in a cohort of young adult injection drug users, Chicago 1997-1999. Ann Epidemiol 2000; 10: 472-3.
15. Tortu S., Neaigus A., McMahon J., Hagen D. Hepatitis C among noninjecting drug users: a report. Subst Use Misuse 2001; 36: 523-34.
16. Millson P., Myers T., Calzavara L., Wallace E., Major C., Degani N. Regional variation in HIV prevalence and risk behaviours in Ontario injection drug users (IDU). Can J Public Health 2003; 94: 431-5.
17. Roy E., Haley N., Leclerc P., Boivin J. F., Cedras L., Vincelette J. Risk factors for hepatitis C virus infection among street youths. Can Med Assoc J 2001; 165: 557-60.
18. Ross M. W., Hwang L.-Y., Zack C., Bull L., Williams M. Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. Int J STD AIDS 2002; 13: 769-74.
19. Ross M. W., Hwang L.-Y., Leonard L., Teng M., Duncan L. Crack Cocaine as a Major Risk for HIV Transmission in a Crack House Population. Houston, TX: TCADA Research Briefs; 1997.
20. Hirche T. O., Lambrecht E., Wagner T. O. Crack syndrome: the pulmonary complications of inhaled cocaine. A review apropos a case report. Pneumologie 2002; 56: 684-8.
21. McElroy P., Rothenberg R., Varghese R., Woodruff R., Minns G., Muth S. et al. A network-informed approach to investigating a tuberculosis outbreak: implications for enhancing contact investigations. Int J Tuberc Lung Dis 2003; 7: S486-93.
22. Nuttbrock L., Rosenblum A., Magura S., McQuistion H. L., Joseph H. The association between cocaine use and HIV/STDs among soup kitchen attendees in New York City. J Acquir Immune Defic Syndr 2000; 25: 86-91.
23. Inciardi J. A., Surratt H. L. Drug use, street crime, and sex-trading among cocaine-dependent women: implications for public health and criminal justice policy. J Psychoact Drugs 2001; 33: 379-89.
24. Newman P., Rhodes F., Weiss R. Correlates of sex trading among drug-using men who have sex with men. Am J Public Health 2004; 94: 1998-2003.
25. Ouellet L. J., Wiebel W. W., Jimenez A. D., Johnson W. A. Crack cocaine and the transformation of prostitution in three Chicago neighborhoods. In: Ratner M. S., editor. Crack pipe as pimp: an ethnographic investigation of sex-for-crack exchanges. New York: Lexington Books; 1993, p. 69-96.
26. Kral A., Bluthenthal R., Booth R., Watters J. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health 1998; 88: 108-13.
27. Booth R., Watters J., Chitwood D. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health 1993; 83: 1144-8.
28. Flom P., Friedman S., Kottiri B., Neaigus A., Curtis R., Des Jarlais D. et al. Stigmatized drug use, sexual partner concurrency, and other sex risk network and behavior characteristics of 18- to 24-year old youth in a high-risk neighborhood. Sex Transm Dis 2001; 28: 598-607.
29. Booth R. E., Kwiatkowski C. F., Chitwood D. D. Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend 2000 March 1; 58: 219-26.
30. Seaman S., Brettle R., Gore S. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ 1998; 316: 426-8.
31. Porter J., Bonilla L., Drucker E. Methods of smoking crack as a potential risk factor for HIV infection: crack smokers' perceptions and behavior. Contemp Drug Problems 1997; 24: 219-347.
32. Johnson R., Gerstein D., Pach A3 Cerbone F., Brown J. HIV risk behaviors in African American drug injector networks: implications of injection-partner mixing and partnership characteristics. Addiction 2002; 97: 1011-24.
33. Roy E., Haley N., Leclerc P., Cedras L., Blais L., Boivin J. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health 2003; 80: 92-105.
34. Page-Shafer K. A., Cahoon-Young B., Klausner J. D., Morrow S., Molitor F. et al. Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection. Am J Public Health 2002; 92: 670-6.
35. Logan T. K., Leukefeld C. Sexual and drug use behaviors among female crack users: a multi-site sample. Drug Alcohol Depend 2000; 58: 237-45.
36. Butters J., Erickson P. Meeting the health care needs of female crack users: a Canadian example. Women Health 2003; 37: 1-17.
37. Cross J., Johnson B., Rees Davis W., James Liberty H. Supporting the habit: income generation activities of frequent crack users compared with frequent users of other hard drugs. Drug Alcohol Depend 2001; 64: 191-201.
38. Brunelle N., Brochu S., Cousineau M. Drug-crime relations among drug-consuming juvenile delinquents: a tripartite model and more. Contemp Drug Problems 2000; 7: 835-66.
39. Inciardi J., Pottieger A. Crack cocaine use and street crime. J Drug Issues 1994; 24: 273-92.
40. Best D., Sidwell C., Gossop M., Harris J., Strang J. Crime and expenditure amongst polydrug misusers seeking treatment: the connection between prescribed methadone and crack use, and criminal involvement. Br J Criminol 2001; 41: 119-26.
41. Kang S. Y., Magura S., Shapiro J. L. Correlates of cocaine/crack use among inner-city incarcerated adolescents. Am J Drug Alcohol Abuse 1994; 20: 413-29.
42. Inciardi J. A., Pottieger A. E. Drug use and street crime in Miami: an (almost) twenty-year retrospective. Subst Use Misuse 1998; 33: 1839-70.
43. Metsch L. R., McCoy C. B. Drug treatment experiences: rural and urban comparisons. Subst Use Misuse 1999; 34: 763-84.
44. Booth R. E., Kwiatkowski C. F., Weissman G. Health-related service utilization and HIV risk behaviors among HIV infected injection drug users and crack smokers. Drug Alcohol Depend 1999; 55: 69-78.
45. Ottaway C. A., Erickson P. G. Frequent medical visits by cocaine-using subjects in a Canadian community: an invisible problem for health practitioners? J Subst Abuse Treat 1997; 14: 423-9.
46. Semaan S., Des Jarlais D., Sogolow E., Johnson W., Hedges L., Ramirez G. et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr 2002; 30: S73-93.
47. Maude-Griffin P.M., Hohenstein J. M., Humfleet G. L., Reilly P. M., Tusel D. J., Hall S. M. Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects. J Consult Clin Psychol 1998; 66: 832-7.
48. Haydon E., Chorny Y., Fischer B. Crack Use and Public Health (with Specific Focus on Hepatitis C): Epidemiology, Risk Factors and Interventions. Ottawa: Public Health Agency for Canada; 2005.
49. Fischer B., Rehm J., Brissette S., Brochu S., Bruneau J., el-Guebaly N. et al. Illicit opioid use in Canada: comparing social, health and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health 2005; 82: 250-66.
50. SAS Inc. SAS System for Windows, version 9. 1 [computer program]. SAS Inc.: Cary, NC, USA. 2005.
51. Prinzleve M., Haasen C., Zurhold H., Matali J., Bruguera E., Gerevich J. et al. Cocaine use in Europe - a multi-centre study: patterns of use in different groups. Eur Addict Res 2004; 10: 147-56.
52. Prinzleve M., Haasen C., Cocaine E. U., Student Group. Cocaine hydrochloride and crack: a comparison of cocaine-use groups without intravenous cocaine use and without opiate use. Sucht 2005; 51: 209-16.
53. Degenhardt L., Conroy E., Gilmour S., Collins L. The effect of a reduction in heroin supply in Australia upon drug distribution and acquisitive crime. Br J Criminol 2005; 45: 2-24.
54. Barrio G. F. L., Royuela L., Diaz A., Rodriguez-Artalejo F. Cocaine use among heroin users in Spain: the diffusion of crack and cocaine smoking. Spanish Group for the Study on the Route of Administration of Drugs. J Epidemiol Commun Health 1998; 52: 172-80.
55. Falck R. S., Wang J., Carlson R. G., Siegal H. A. Crack-cocaine use and health status as defined by the SF-36. Addict Behav 2000; 25: 579-84.
56. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). State of the Drugs Problem in the. European Union and Norway. Annual Report. Lisbon: EMCDDA; 2003.
57. Stover H. Bestandsaufnahme Crack-Konsum in Deutschland. Verbreitung, Konsummuster, Risiken und Hilfsangebote [Situation assessment of crack use in Germany: prevalence, use patterns, risks and interventions]. In: Stover H., Prinzleve M., editors. Kokain und crack. Freiburg: Lambertus; 2004, p. 50-128.
58. Baumer E., Lauritsen J., Rosenfeld R., Wright R. The influence of crack cocaine on robbery, burglary and homicide rates: a cross-city longitudinal analysis. J Res Criminol Del 1998; 35: 316-40.
59. Fischer B. Illegale Opiatsucht, Behandlung und ökonomische Kostenforschung - ein beispielhafter Überblick und eine Diskussion aus sozialwissenschaftlicher Perspektive [Illicit opioid dependence, treatment and economic cost research - a selective review and discussion from a social science perspective]. Sucht 2003; 4: 2-7.
60. Miller J., Cohen A., Bryany K. On the demise and morrow of subculture theories of crime and delinquency. J Crime Justice 1997; 20: 167-78.
61. Byqvist S., Olsson B. Male drug abuse, criminality and subcultural affiliation in a career perspective. J Psychoact Drugs 1998; 30: 68.
62. Hubbard P. Cleansing the metropolis: sex work and the politics of zero tolerance. Urban Studies 2004; 41: 1687-702.
63. Fischer B., Turnbull S., Poland B., Haydon E. Governing drug use: Supervised Injection Facilities as a case study in the government of health, risk and space. Int J Drug Policy 2004; 15: 357-65.
64. Dixon D., Coffin P. Zero tolerance policing of illegal drug markets. Drug Alcohol Rev 1999; 18: 477-86.
65. Schmid M., Vogt I. The use of consumption rooms in Frankfurt/Main with special consideration of the use of crack. Sucht 2005; 51: 233-9.
66. Orwin R. G., Scott C. K., Arieira C. Transitions through homelessness and factors that predict them: three-year treatment outcomes. J Subst Abuse Treat 2005; 28: S23-S39.
67. van den Brink W. Epidemiology of cocaine and crack: implications for drug policy and treatment planning. Sucht 2005; 51: 196-8.
68. Fischer B., Brissette S., Brochu S., Bruneau J., el-Guebaly N., Noël L. et al. Prevalence and determinants of overdose incidents among illicit opioid users in five cities across Canada. Can Med Assoc J 2004; 171: 235-9.
69. Palepu A., Strathdee S. A., Hogg R. S., Anis A. H., Rae S., Cornelisse P. G. A. et al. The social determinants of emergency department and hospital use by injection drug users in Canada. J Urban Health 1999; 76: 409-18.
70. Patrick D. M., Tyndall M. W., Cornelisse P. G., Li K., Sherlock C. H., Rekart M. L. et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Can Med Assoc J 2001; 165: 889-95.
71. Falck R. S., Wang J., Siegal H. A., Carlson R. G. Current physical health problems and their predictors among a community sample of crack-cocaine smokers in Ohio. J Psychoact Drugs 2003; 35: 471-8.
72. Fischer B., Remis R., Haydon E. Hepatitis C, illegale Drogen und marginalisierte Populationen in Kanada. Ein kurzer Uberblick zu Epidemiologie, Pravention und Behandlung [Hepatitis C, illegal drugs and marginalized populations in Canada. A review of epidemiology, prevention and treatment]. In: Stover H, editor. Tagungsband Zum, 1. Berlin: Internationalen Fachtag zu Hepatitis C; 2004, p. 131-44.
73. Thorpe L. E., Ouellet L. J., Levy J. R., Williams I. T., Monterroso E. R. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-99. J Infect Dis 2000; 182: 1588-94.
74. van B. I., Dwyer R., Dore G. J., Luo K., Kaldor J. M. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ 1998; 317: 433-7.
75. Edlin B. R., Kresina T. F., Raymond D. B., Carden M. R., Gourevitch M. N., Rich J. D. et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005; 40: S276-85.
76. Falck R. S., Wang J., Carlson R. G., Eddy M., Siegal H. A. The prevalence and correlates of depressive symptomatology among a community sample of crack-cocaine smokers. J Psychoact Drugs 2002; 34: 281-8.
77. Watkins K. E., Hunter S. B., Wenzel S. L., Tu W., Paddock S. M., Griffin A. et al. Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. Am J Drug Alcohol Abuse 2004; 30: 749-64.
78. Hatsukami D. K., Fischman M. W. Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? JAMA 1996; 276: 1580-8.
79. Khantzian E. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Rev Psychiatry 1997; 4: 231-24.
80. Fischer B., Rehm J., Kim G., Kirst M. Eyes wide shut? A conceptual and empirical critique of methadone maintenance treatment. Eur Addict Res 2005; 11: 1-12.
81. Wild C., el-Guebaly N., Fischer B., Brissette S., Brissette S., Bruneau J. et al. Comorbid depression among opiate users: results from a multisite Canadian study. Can J Psychiatry 2005; 50: 512-8.
82. Hedrich D. European Report on Drug Consumption Rooms. Lisbon: European Monitoring Centre on Drugs and Drug Addiction (EMCDDA); 2004.
83. Fischer B., Bisceglia D., Daniel N., Gliksman L. Methadone treatment in Ontario - results of a physician survey. Ann Med Internes 2002; 153: S11-21.
84. Best D., Harris J., Gossop M., Farrell M., Finch E., Noble A. et al. Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment. Drug Alcohol Rev 2000; 19: 9-16.
85. Beswick R., Best D., Rees S., Coomber R., Gossop M., Strang J. Multiple drug use: patterns and practices of heroin and crack use in a population of opiate addicts in treatment. Drug Alcohol Rev 2001; 20: 201-4.
86. Watters J., Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Problems 1989; 36: 416-30.
87. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend 1998; 51: 253-62.
88. Harrison L. The validity of self-reported data on drug use. J Drug Issues 1995; 25: 91-111.
89. Research Group on Drug Use. Drug Use in Toronto. Toronto: Research Group on Drug Use; 2004.